Decoy Therapeutics (DCOY.US) Shareholders - Institutional Holders, Major Shareholders & Insiders | Longbridge

Shareholder Type

Public and others88.70%
Individuals & Insiders10.50%
Institutions0.80%

Major Shareholders

Major Shareholders Latest
Shareholder
Frederick PierceCEO & Director	5.32%	34.84K	5.06%	+33.46K	08/31/2026
Mark RosenblumExecutive VP of Finance & CFO	1.73%	11.36K	1.42%	+9.68K	08/31/2026
Barbara HibnerChief Scientific Officer	0.64%	4.22K	0.64%	+4.22K	08/31/2026
Vanguard Capital Management, LLC	0.62%	4.03K	--	+4.03K	06/30/2026
Peter MarschelChief Business Officer	0.60%	3.90K	0.60%	+3.90K	08/31/2026
Arnold HanishIndependent Director	0.52%	3.42K	0.52%	+3.42K	08/31/2026
William McVicarIndependent Chairman of the Board	0.46%	3.00K	0.46%	+3.00K	08/31/2026
Teresa BurlesonIndependent Director	0.31%	2.00K	0.31%	+2.00K	08/31/2026
Jonathan LieberIndependent Director	0.31%	2.00K	0.31%	+2.00K	08/31/2026
Paul LammersIndependent Director	0.31%	2.00K	0.31%	+2.00K	08/31/2026
Patricia GauthierDirector	0.31%	2.00K	--	+2.00K	08/31/2026
Geode Capital Management, LLC	0.14%	910.00	0.03%	+0	12/31/2025
Tower Research Capital Europe Limited	0.04%	256.00	0.15%	-765.00	06/30/2026
David ArthurFormer Director	<0.01%	34.00	<0.01%	+0	04/30/2026
UBS Asset Management AG	<0.01%	25.00	0.10%	-521.00	06/30/2026
Caitong International Asset Management Co., Limited	<0.01%	2.00	--	+2.00	06/30/2026
Bruce McCreedyFormer Interim Chief Scientific Officer & Independent Director	<0.01%	1.00	<0.01%	+0	10/24/2025
Advisory Services Network, LLC	0.00%	0.00	<0.01%	-41.00	06/30/2026
Morgan Stanley	0.00%	0.00	<0.01%	-1.00	06/30/2026
Armistice Capital LLC	0.00%	0.00	0.08%	-421.00	06/09/2026